Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Free Articles

Week in Review: Hengrui Out-Licenses Next-Gen PARP1 to Merck KGaA for $1.7 Billion
Week in Review: Hansoh Sells ex-China ADC Rights to GSK in $1.6 Billion Deal
Week in Review: China's Biopharmas Announce $2.5 Billion in Deals
Week in Review: Two China Biopharmas Announce Billion Dollar Deals
Week in Review: QYuns Plans Hong Kong IPO for Autoimmune/Allergic Disease Portfolio
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital